Titre
New synthetic opioids: Part of a new addiction landscape
Type
article
Institution
Externe
Périodique
Auteur(s)
Karila, Laurent
Auteure/Auteur
Marillier, Maude
Auteure/Auteur
Chaumette, Boris
Auteure/Auteur
Billieux, Joël
Auteure/Auteur
Franchitto, Nicolas
Auteure/Auteur
Benyamina, Amine
Auteure/Auteur
Liens vers les personnes
ISSN
0149-7634
Statut éditorial
Publié
Date de publication
2019
Volume
106
Première page
133
Dernière page/numéro d’article
140
Peer-reviewed
Oui
Langue
anglais
Résumé
Synthetic opioids (SO) are a major risk for public health across the world. These drugs can be divided into 2
categories, pharmaceutical and non-pharmaceutical fentanyls. A new generation of SO has emerged on the drug
market since 2010. North America is currently facing an opioid epidemic of morbi-mortality, caused by overprescription
of opioids, illegally diverted prescribed medicines, the increasing use of heroin and the emergence
of SO. Furthermore, this opioid crisis is also seen in Europe. SO are new psychoactive substances characterized
by different feature such as easy availability on the Internet, low price, purity, legality, and lack of detection in
laboratory tests. They have not been approved or are not recommended for human use. Opioid misuse is associated
with somatic and psychiatric complications. For many substances, limited pharmacological information
is available, increasing the risk of harmful adverse events. Health actors and the general population need to be
clearly informed of the potential risks and consequences of the diffusion and use of SO.
categories, pharmaceutical and non-pharmaceutical fentanyls. A new generation of SO has emerged on the drug
market since 2010. North America is currently facing an opioid epidemic of morbi-mortality, caused by overprescription
of opioids, illegally diverted prescribed medicines, the increasing use of heroin and the emergence
of SO. Furthermore, this opioid crisis is also seen in Europe. SO are new psychoactive substances characterized
by different feature such as easy availability on the Internet, low price, purity, legality, and lack of detection in
laboratory tests. They have not been approved or are not recommended for human use. Opioid misuse is associated
with somatic and psychiatric complications. For many substances, limited pharmacological information
is available, increasing the risk of harmful adverse events. Health actors and the general population need to be
clearly informed of the potential risks and consequences of the diffusion and use of SO.
Sujets
PID Serval
serval:BIB_22AF40B11434
PMID
Date de création
2020-01-10T08:30:27.469Z
Date de création dans IRIS
2025-05-20T13:21:43Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
Karila_NBR_2019.pdf
Version du manuscrit
published
Taille
1.47 MB
Format
Adobe PDF
PID Serval
serval:BIB_22AF40B11434.P001
Somme de contrôle
(MD5):c23c4fa3ea257cea2595be4f33e114d2